AC Immune SA
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| ACIU | PRTA | ALEC | PMN | ABOS | KRSA | |
|---|---|---|---|---|---|---|
| Market cap | 243.60M | 432.77M | 232.25M | 84.74M | 146.08M | 1.55B |
| P/E (TTM) | — | — | — | — | — | — |
| Forward P/E | 4.1 | -5.5 | -2.8 | -2.1 | -1.4 | -9.6 |
| Price/book | 5.8 | 1.5 | -23.4 | 1.7 | 2.6 | -4.3 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −20.20% | −14.59% | −30.43% | −19.92% | −13.30% | +110.68% |
| Today | −2.00% | −4.64% | 0.00% | −1.66% | −5.61% | +0.35% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All ACIU news ›AC Immune director Graney reports 12,959 common shares
AC Immune SA (NASDAQ: ACIU) is a clinical-stage biopharmaceutical company developing precision immunotherapies and diagnostics for neurodegenerative diseases. - [Form 3] AC Immune SA Initial Statement of Beneficial Ownership AC Immune…
AC Immune Parkinson’s Vaccine Study Meets Safety, Immunogenicity Goals
Posted by Danessa Lincoln on Sep 29th, 2026 AC Immune (NASDAQ:ACIU) reported results from Part 1 of its VacSYn Phase II trial evaluating ACI-7104.056, an active immunotherapy designed to target aggregated alpha-synuclein in early…
AC Immune Posts Strong Week-100 Phase 2 Data for Parkinson’s Vaccine ACI-7104
AC Immune SA ( (ACIU) ) has shared an announcement. The most recent analyst rating on (ACIU) stock is a Buy with a $12.00 price target. To see the full list of analyst forecasts on AC Immune SA stock, see the ACIU Stock Forecast page.…
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
-
stocktitan.net1
-
theglobeandmail.com1
Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 2 articles, not a forecast.